Cargando…

Shikonin as a WT1 Inhibitor Promotes Promyeloid Leukemia Cell Differentiation

This study aims to observe the differentiating effect of shikonin on Wilms’ tumor 1 (WT1)-positive HL-60 cells and investigate the fate of the differentiated leukemia cells. WT1 overexpression unaffected cell viability but promoted resistance to H(2)O(2)-induced DNA injury and cell apoptosis. The bi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Zhenzhen, Sun, Luyao, Xia, Haojie, Tian, Shibin, Liu, Mengyue, Hou, Jiejie, Li, Jiahuan, Lin, Haihong, Du, Gangjun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9735585/ https://www.ncbi.nlm.nih.gov/pubmed/36500358 http://dx.doi.org/10.3390/molecules27238264

Ejemplares similares

Chromatin topology reorganization and transcription repression by PML-RARα in acute promyeloid leukemia
por: Wang, Ping, et al.
Publicado: (2020)

Near neighbour analysis of variant cell lines derived from the promyeloid cell line HL60.
por: Bunce, C. M., et al.
Publicado: (1988)

The anti-leukemia activity and mechanisms of shikonin: a mini review
por: Dong, Han, et al.
Publicado: (2023)

WT1 peptide analogue WT1-126Y enhances leukemia lysis
por: Alqudaihi, Ghofran, et al.
Publicado: (2014)

Research Status and Hotspots of Anticancer Natural Products Based on the Patent Literature and Scientific Articles
por: Shen, Junkai, et al.
Publicado: (2022)

Shikonin overcomes drug resistance and induces necroptosis by regulating the miR-92a-1-5p/MLKL axis in chronic myeloid leukemia
por: Huang, Xianbo, et al.
Publicado: (2020)

Shikonin induces ferroptosis in multiple myeloma via GOT1-mediated ferritinophagy
por: Li, Wenxia, et al.
Publicado: (2022)

Evaluation of herb-drug interaction of ambrisentan with shikonin based on UPLC-MS/MS
por: Lan, Tian, et al.
Publicado: (2021)

Evaluation of radical scavenging properties of shikonin
por: Yoshida, Lucia S., et al.
Publicado: (2014)

Promising Nanomedicines of Shikonin for Cancer Therapy
por: Yan, Chunmei, et al.
Publicado: (2023)

Integrative analysis of the shikonin metabolic network identifies new gene connections and reveals evolutionary insight into shikonin biosynthesis
por: Suttiyut, Thiti, et al.
Publicado: (2022)

Tumor suppressor function of WT1 in acute promyelocytic leukemia
por: Christopher, Matthew J., et al.
Publicado: (2021)

Berberine and cinnamaldehyde together prevent lung carcinogenesis
por: Meng, Mingjing, et al.
Publicado: (2017)

WT1 Gene Mutations, rs16754 Variant, and WT1 Overexpression as Prognostic Factors in Acute Myeloid Leukemia Patients
por: Koczkodaj, Dorota, et al.
Publicado: (2022)

PKM2 Inhibitor Shikonin Overcomes the Cisplatin Resistance in Bladder Cancer by Inducing Necroptosis
por: Wang, Yonggang, et al.
Publicado: (2018)

Selectively targeting FLT3-ITD mutants over FLT3- wt by a novel inhibitor for acute myeloid leukemia
por: Wang, Aoli, et al.
Publicado: (2020)

Shikonin induces apoptosis in the human gastric cancer cells HGC-27 through mitochondria-mediated pathway
por: Hou, Yue, et al.
Publicado: (2015)

Shikonin-enhanced cell immunogenicity of tumor vaccine is mediated by the differential effects of DAMP components
por: Lin, Tien-Jen, et al.
Publicado: (2015)

Effect of Shikonin Against Candida albicans Biofilms
por: Yan, Yu, et al.
Publicado: (2019)

Shikonin Inhibits Fin Regeneration in Zebrafish Larvae
por: Cao, Zigang, et al.
Publicado: (2022)

Shikonin, dually functions as a proteasome inhibitor and a necroptosis inducer in multiple myeloma cells
por: WADA, NAOKO, et al.
Publicado: (2014)

Nec-1 Enhances Shikonin-Induced Apoptosis in Leukemia Cells by Inhibition of RIP-1 and ERK1/2
por: Han, Weidong, et al.
Publicado: (2012)

Shikonin Induces ROS-Dependent Apoptosis Via Mitochondria Depolarization and ER Stress in Adult T Cell Leukemia/Lymphoma
por: Boonnate, Piyanard, et al.
Publicado: (2023)

Oral kanglaite injection (KLTI) attenuates the lung cancer-promoting effect of high-fat diet (HFD)-induced obesity
por: Cao, Ning, et al.
Publicado: (2016)

Upregulation of Succinate Dehydrogenase (SDHA) Contributes to Enhanced Bioenergetics of Ovarian Cancer Cells and Higher Sensitivity to Anti-Metabolic Agent Shikonin
por: Wang, Lin, et al.
Publicado: (2022)

Natural Shikonin Potentially Alters Intestinal Flora to Alleviate Acute Inflammation
por: Liang, Ying, et al.
Publicado: (2023)

Shikonin Inhibits Cancer Through P21 Upregulation and Apoptosis Induction
por: Wang, Fangfang, et al.
Publicado: (2020)

Differential microbial assemblages associated with shikonin-producing Borage species in two distinct soil types
por: Fazal, Aliya, et al.
Publicado: (2021)

An Oxidative Stress Mechanism of Shikonin in Human Glioma Cells
por: Yang, Jen-Tsung, et al.
Publicado: (2014)

Mechanisms Behind the Inhibition of Lung Adenocarcinoma Cell by Shikonin
por: Lan, Wenjing, et al.
Publicado: (2014)

Shikonin Functionalized Packaging Film for Monitoring the Freshness of Shrimp
por: Roy, Swarup, et al.
Publicado: (2022)

Senescence Inducer Shikonin ROS-Dependently Suppressed Lung Cancer Progression
por: Zheng, Hongming, et al.
Publicado: (2018)

Shikonin suppresses proliferation and induces apoptosis in human leukemia NB4 cells through modulation of MAPKs and c-Myc
por: Shan, Zhi-Ling, et al.
Publicado: (2017)

Shikonin Derivatives from Onsoma visianii Decrease Expression of Phosphorylated STAT3 in Leukemia Cells and Exert Antitumor Activity
por: Todorovic, Zeljko, et al.
Publicado: (2021)

Chemical screen identifies shikonin as a broad DNA damage response inhibitor that enhances chemotherapy through inhibiting ATM and ATR
por: Wang, Fangfang, et al.
Publicado: (2022)

Implications of the Wilms’ Tumor Suppressor Wt1 in Cardiomyocyte Differentiation
por: Wagner, Nicole, et al.
Publicado: (2021)

Distinct Metabolic features differentiating FLT3-ITD AML from FLT3-WT childhood Acute Myeloid Leukemia
por: Stockard, Bradley, et al.
Publicado: (2018)

Preparation, cellular uptake and angiogenic suppression of shikonin-containing liposomes in vitro and in vivo
por: Xia, Hongmei, et al.
Publicado: (2013)

Corrigendum: Shikonin Inhibits Cancer Through P21 Upregulation and Apoptosis Induction
por: Wang, Fangfang, et al.
Publicado: (2020)

Differential relieving effects of shikonin and its derivatives on inflammation and mucosal barrier damage caused by ulcerative colitis
por: Han, Hongwei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vanf3gk0vrdc5mleb0guce085b